🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Pagal sudedamųjų dalių sąrašą, produkte yra oktametilciklotetrasiloksano (D4), kuris yra draudžiamas nenuplaunamose kosmetikos priemonėse. D4 gali pakenkti reprodukcinei sveikatai. Produktas neatitinka Kosmetikos gaminių reglamento.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Withdrawal of the product from the market
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): SILK Therapy ORIGINAL
Risk Description (original English): According to the list of ingredients, the product contains octamethylcyclotetrasiloxane (D4), which is prohibited in leave-on cosmetics. D4 may damage reproductive health.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.